Abstract:The COVID-19 pandemic has created significant concern for everyone. Recent data from many worldwide reports suggest that most infections are caused by the Omicron variant and its sub-lineages, dominating all the previously emerged variants. The numerous mutations in Omicron's viral genome and its sub-lineages attribute it a larger amount of viral fitness, owing to the alteration of the transmission and pathophysiology of the virus. With a rapid change to the viral structure, Omicron and its sub-variants, namely BA.1, BA.2, BA.3, BA.4, and BA.5, dominate the community with an ability to escape the neutralization efficiency induced by prior vaccination or infections. Similarly, several recombinant sub-variants of Omicron, namely XBB, XBD, and XBF, etc., have emerged, which a better understanding. This review mainly entails the changes to Omicron and its sub-lineages due to it having a higher number of mutations. The binding affinity, cellular entry, disease severity, infection rates, and most importantly, the immune evading potential of them are discussed in this review. A comparative analysis of the Delta variant and the other dominating variants that evolved before Omicron gives the readers an in-depth understanding of the landscape of Omicron's transmission and infection. Furthermore, this review discusses the range of neutralization abilities possessed by several approved antiviral therapeutic molecules and neutralizing antibodies which are functional against Omicron and its sub-variants. The rapid evolution of the sub-variants is causing infections, but the broader aspect of their transmission and neutralization has not been explored. Thus, the scientific community should adopt an elucidative approach to obtain a clear idea about the recently emerged sub-variants, including the recombinant variants, so that effective neutralization with vaccines and drugs can be achieved. This, in turn, will lead to a drop in the number of cases and, finally, an end to the pandemic.

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness

Evolution and Implications of SARS-CoV-2 Variants in the Post-Pandemic Era

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages

Evolutionary Dynamics of the Severe Acute Respiratory Syndrome Coronavirus 2 Genomes

Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion

SARS-CoV-2 Omicron variant: recent progress and future perspectives

On the Origin and Continuing Evolution of SARS-CoV-2

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants

SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants

Emerging SARS-CoV-2 Variants: Why, How, and What's Next?

SARS-CoV-2 variant biology: immune escape, transmission and fitness

The evolution of SARS-CoV-2 and the COVID-19 pandemic

SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies

The potential impact of the spreading of highly transmissible Omicron variant XBB.1.5 and JN.1 on the evolution of SARS-CoV-2

Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity

SARS-CoV-2 Omicron variant: Immune escape and vaccine development

Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology

Evolution of a Distinct SARS-CoV-2 Lineage Identified during an Investigation of a Hospital Outbreak

Omicron variant genome evolution and phylogenetics